MedTrace Logo

Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy

NCT02225418 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-07-22

No results posted yet for this study

Summary

The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder.

The trial will compare active TQL block versus placebo TQL block after said operation.

The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.

Conditions

  • Cholecystitis
  • Pain

Interventions

DRUG

Ropivacaine

DRUG

saline

Sponsors & Collaborators

  • Bispebjerg Hospital

    collaborator OTHER

  • Jens Borglum Neimann

    lead OTHER

Principal Investigators

  • Jens Børglum, MD, PhD · Copenhagen University Hospital Bispebjerg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02225418 on ClinicalTrials.gov